JP2024517740A5 - - Google Patents
Info
- Publication number
- JP2024517740A5 JP2024517740A5 JP2023566500A JP2023566500A JP2024517740A5 JP 2024517740 A5 JP2024517740 A5 JP 2024517740A5 JP 2023566500 A JP2023566500 A JP 2023566500A JP 2023566500 A JP2023566500 A JP 2023566500A JP 2024517740 A5 JP2024517740 A5 JP 2024517740A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- nrarc
- heterocyclyl
- orc
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE2150555-7 | 2021-04-30 | ||
| SE2150555 | 2021-04-30 | ||
| SE2130172-6 | 2021-06-22 | ||
| SE2130172 | 2021-06-22 | ||
| SE2230036-2 | 2022-02-04 | ||
| SE2230036 | 2022-02-04 | ||
| PCT/EP2022/061628 WO2022229458A1 (en) | 2021-04-30 | 2022-04-29 | Substituted hydantoin compounds, methods for preparation thereof and use thereof in the treatment and/or prevention of a corona virus disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024517740A JP2024517740A (ja) | 2024-04-23 |
| JP2024517740A5 true JP2024517740A5 (enExample) | 2025-04-02 |
Family
ID=81653697
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023566500A Pending JP2024517740A (ja) | 2021-04-30 | 2022-04-29 | 置換ヒダントイン化合物、その調製方法、並びにコロナウイルス疾患の治療及び／又は予防におけるその使用 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20240383890A2 (enExample) |
| EP (1) | EP4329883A1 (enExample) |
| JP (1) | JP2024517740A (enExample) |
| WO (1) | WO2022229458A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024017178A1 (en) * | 2022-07-18 | 2024-01-25 | Avitar Biosciences, Inc. | Substituted hydantoin compounds, pharmaceutical compositions, and therapeutic applications |
| CN115894443B (zh) * | 2022-11-17 | 2024-03-29 | 上海市重大传染病和生物安全研究院 | 一种化合物艾奎斯韦及其应用 |
| WO2025196284A1 (en) | 2024-03-22 | 2025-09-25 | Carlsson Jens | Substituted hydantoin compounds, methods for preparation thereof and use thereof in the treatment and/or prevention of a coronavirus disease |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007047146A2 (en) * | 2005-10-11 | 2007-04-26 | Intermune, Inc. | Inhibitors of viral replication |
| EP3351188B1 (en) | 2015-09-17 | 2021-04-07 | Olympus Corporation | Endoscope treatment instrument |
| US11572370B2 (en) * | 2018-01-08 | 2023-02-07 | Biohaven Therapeutics Ltd. | CD16A binding agents and uses thereof |
-
2022
- 2022-04-29 WO PCT/EP2022/061628 patent/WO2022229458A1/en not_active Ceased
- 2022-04-29 US US18/556,116 patent/US20240383890A2/en active Pending
- 2022-04-29 EP EP22723459.8A patent/EP4329883A1/en active Pending
- 2022-04-29 JP JP2023566500A patent/JP2024517740A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12331056B2 (en) | SHP2 phosphatase inhibitors and methods of use thereof | |
| US12233062B2 (en) | Heterocyclic derivatives useful as SHP2 inhibitors | |
| JP2024517693A (ja) | ２－アミノベンゾチアゾール化合物及びその使用方法 | |
| JP2024517693A5 (enExample) | ||
| JP2024532733A (ja) | 複素環式化合物及び使用方法 | |
| JP2024517740A5 (enExample) | ||
| JP2025533831A (ja) | Ｋｒａｓ ｇ１２ｃ変異タンパク質のテザー型複素環式阻害剤及びその使用 | |
| WO2023018812A1 (en) | Heterocyclic compounds and methods of use | |
| JP2022533120A5 (enExample) | ||
| JP2021528467A5 (enExample) | ||
| CA3107411A1 (en) | Heterobicyclic compounds for inhibiting the activity of shp2 | |
| ES2807785T3 (es) | Compuestos de heteroarilamina bicíclicos como inhibidores de pi3k | |
| KR920019794A (ko) | 융합 헤테로시클릭 화합물, 그의 제조방법 및 용도 | |
| CA2610888A1 (en) | Inhibitors of akt activity | |
| JP2018500376A5 (enExample) | ||
| HRP20120105T1 (hr) | Aminoheterociklički spojevi | |
| RU2011116447A (ru) | Модуляторы амилоида бета | |
| JP2013500975A5 (enExample) | ||
| JP2016537384A5 (enExample) | ||
| JP2020526549A5 (enExample) | ||
| US12180226B2 (en) | Spirotricycle RIPK1 inhibitors and methods of uses thereof | |
| RU2005131497A (ru) | Фармацевтическая композиция для предотвращения и лечения аддикции к никотину у млекопитающего | |
| WO2026017844A1 (en) | Combination therapies comprising a mettl3 inhibitor and a bcl2 inhibitor | |
| TH2401004994A (th) | อิมิดาโซลมาโครไซเคิลสำหรับการบำบัดของโรคภูมิต้านต่อตนเอง | |
| RU2025105090A (ru) | Новые гетероциклические соединения |